Celularity Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Celularity Inc. (CELU) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-57.89-196.3014.19-100.12-208.23
Depreciation & Amortization7.929.329.448.828.17
Deferred Income Tax0.000.000.00-1.350.00
Stock Based Compensation11.5715.0215.8640.014.37
Change in Working Capital22.203.25-17.98-11.083.60
Change in Accounts Receivable-3.97-6.83-3.58-1.911.65
Change in Inventory6.28-0.87-16.89-6.42-0.64
Change in Accounts Payable9.248.50-2.953.010.31
Change in Other Working Capital10.65-92.31-123.672.62-1.81
Other Operating Activities9.80-92.31-123.67-48.02-5.24
Net Cash from Operating Activities-6.40-38.69-137.88-110.10-63.19
Investing Activities
Capital Expenditures-0.16-4.05-5.24-6.20-27.83
Acquisitions-1.500.00-126.280.000.00
Sales/Maturities of Investments0.00-3.000.000.000.00
Other Investing Activities2.180.000.000.300.00
Net Cash from Investing Activities0.51-4.05-5.24-5.90-12.82
Financing Activities
Debt Repayment7.10-16.81-2.60-5.000.00
Common Stock Issued0.0621.8936.52104.040.14
Common Stock Repurchased0.00-0.10-0.130.00-0.26
Other Financing Activities-0.46-1.65-3.23-5.4817.54
Net Cash from Financing Activities6.7024.09119.8498.56102.01
Summary
Net Change in Cash0.81-18.64-23.27-17.4426.01
Cash at Beginning of Period10.1628.8052.0869.510.00
Cash at End of Period10.9810.1628.8052.080.00
Free Cash Flow-6.56-42.73-143.11-116.30-91.03
Supplemental Disclosures
Interest Paid0.141.070.000.150.00
Income Taxes Paid0.000.000.000.000.01